Published in Liver Transpl on April 01, 2007
Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol (2011) 3.36
Gene-expression signature of vascular invasion in hepatocellular carcinoma. J Hepatol (2011) 2.39
Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg (2007) 2.12
Liver transplantation for hepatocellular carcinoma: an appraisal of current controversies. Liver Cancer (2012) 0.99
Clinical values of AFP, GPC3 mRNA in peripheral blood for prediction of hepatocellular carcinoma recurrence following OLT: AFP, GPC3 mRNA for prediction of HCC. Hepat Mon (2011) 0.91
Alpha-fetoprotein Level Predicts Recurrence After Transplantation in Hepatocellular Carcinoma. Medicine (Baltimore) (2016) 0.86
Obesity and microvascular invasion in hepatocellular carcinoma. Cancer Invest (2010) 0.85
Liver Transplantation for HCC: A Review. Indian J Surg (2011) 0.82
Adjuvant hepatic intra-arterial iodine-131-lipiodol following curative resection of hepatocellular carcinoma: a prospective randomized trial. World J Surg (2013) 0.82
What is the role of adjuvant therapy after liver transplantation for hepatocellular carcinoma? Liver Transpl (2011) 0.80
Wading through the noise of "multi-omics" to identify prognostic biomarkers in hepatocellular carcinoma. Hepatobiliary Surg Nutr (2015) 0.78
Liver transplantation for hepatocellular carcinoma: analysis of factors predicting outcome in 1074 patients in OPTN Region 5. Clin Transplant (2015) 0.78
Recipient C6 rs9200 genotype is associated with hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population. Cancer Gene Ther (2016) 0.77
Recent advances in liver transplantation for the practicing gastroenterologist. Gastroenterol Hepatol (N Y) (2009) 0.76
Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation. Clin Mol Hepatol (2014) 0.76
Prognosis in the early stages of hepatocellular carcinoma: Predicting outcomes and properly selecting patients for curative options. Can J Gastroenterol (2011) 0.75
In vitro three dimensional culture of hepatocellular carcinoma to measure prognosis and responsiveness to chemotherapeutic agents. Hepatobiliary Surg Nutr (2016) 0.75
Contribution of alpha-fetoprotein in liver transplantation for hepatocellular carcinoma. World J Hepatol (2016) 0.75
Loco-regional therapy in patients with Milan Criteria-compliant hepatocellular carcinoma and short waitlist time to transplant: an outcome analysis. HPB (Oxford) (2012) 0.75
The Clinical Significance and Potential Therapeutic Role of GPx3 in Tumor Recurrence after Liver Transplantation. Theranostics (2016) 0.75
Preoperative prognostic values of α-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) in patients with hepatocellular carcinoma for living donor liver transplantation. Hepatobiliary Surg Nutr (2016) 0.75
Late recurrence of hepatocellular carcinoma after liver transplantation. Hepatoma Res (2017) 0.75
Validity of eleven prognostic scores with respect to intra- and extrahepatic recurrence of hepatocellular carcinoma after liver transplantation. J Cancer Res Clin Oncol (2017) 0.75
A Surgical Perspective on Targeted Therapy of Hepatocellular Carcinoma. Diseases (2015) 0.75
Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients. Hepatology (2011) 3.70
Acute rejection is associated with antibodies to non-Gal antigens in baboons using Gal-knockout pig kidneys. Nat Med (2005) 2.67
Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA). Am J Surg Pathol (2008) 2.30
Mitotic chromosome condensation mediated by the retinoblastoma protein is tumor-suppressive. Genes Dev (2010) 2.12
Oral metastatic hepatocellular carcinoma: a changing demographic in Europe and North America. Immunohistochemical advances in the microscopic diagnosis. Oral Oncol (2010) 2.08
Inferior survival in liver transplant recipients with hepatocellular carcinoma receiving donation after cardiac death liver allografts. Liver Transpl (2013) 2.03
Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection. Hepatology (2010) 2.02
Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants. Free Radic Res (2003) 1.90
Eosinophilic esophagitis in adults: distinguishing features from gastroesophageal reflux disease: a study of 41 patients. Mod Pathol (2006) 1.89
Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography. Liver Int (2012) 1.83
Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation. Liver Transpl (2009) 1.69
National recommendations for donation after cardiocirculatory death in Canada: Donation after cardiocirculatory death in Canada. CMAJ (2006) 1.68
Gastrointestinal stromal tumours: consensus statement on diagnosis and treatment. Can J Gastroenterol (2006) 1.62
Liver transplant outcomes in HIV-infected patients: a systematic review and meta-analysis with synthetic cohort. AIDS (2011) 1.61
MicroRNA-200b regulates vascular endothelial growth factor-mediated alterations in diabetic retinopathy. Diabetes (2011) 1.60
Novel small interfering RNA-containing solution protecting donor organs in heart transplantation. Circulation (2009) 1.60
Burden of disease and cost of chronic hepatitis C infection in Canada. Can J Gastroenterol Hepatol (2014) 1.59
Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase. Circ Res (2008) 1.52
Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation. Transplantation (2004) 1.51
The innate immune response and activation of coagulation in alpha1,3-galactosyltransferase gene-knockout xenograft recipients. Transplantation (2009) 1.47
miR-146a-Mediated extracellular matrix protein production in chronic diabetes complications. Diabetes (2011) 1.47
Heme oxygenase modulates small intestine leukocyte adhesion following hindlimb ischemia/reperfusion by regulating the expression of intercellular adhesion molecule-1. Crit Care Med (2005) 1.47
Carbon monoxide releasing molecules inhibit cell death resulting from renal transplantation related stress. J Urol (2012) 1.46
Calcineurin inhibitor-free mycophenolate mofetil/sirolimus maintenance in liver transplantation: the randomized spare-the-nephron trial. Liver Transpl (2013) 1.46
Regulatory T-cell generation and kidney allograft tolerance induced by mesenchymal stem cells associated with indoleamine 2,3-dioxygenase expression. Transplantation (2010) 1.45
miR133a regulates cardiomyocyte hypertrophy in diabetes. Diabetes Metab Res Rev (2010) 1.44
Pathological effects of drugs on the gastrointestinal tract: a review. Hum Pathol (2007) 1.43
Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database. Liver Transpl (2004) 1.42
Ectopic breast tissue presenting as an anal polyp. Can J Surg (2007) 1.42
Inhibitory feedback loop between tolerogenic dendritic cells and regulatory T cells in transplant tolerance. J Immunol (2003) 1.41
Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells. Am J Physiol Endocrinol Metab (2009) 1.41
Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB. Nutrition (2009) 1.40
A PCR-based amplification method retaining the quantitative difference between two complex genomes. Nat Biotechnol (2002) 1.39
Representing complexity well: a story about teamwork, with implications for how we teach collaboration. Med Educ (2012) 1.38
CD40-CD40 ligand interactions in oxidative stress, inflammation and vascular disease. Trends Mol Med (2008) 1.34
Current practice patterns among pathologists in the assessment of venous invasion in colorectal cancer. J Clin Pathol (2011) 1.33
Mycophenolate mofetil-related gastrointestinal mucosal injury: variable injury patterns, including graft-versus-host disease-like changes. Am J Surg Pathol (2008) 1.23
High glucose induced alteration of SIRTs in endothelial cells causes rapid aging in a p300 and FOXO regulated pathway. PLoS One (2013) 1.20
The total mesorectal excision specimen for rectal cancer: a review of its pathological assessment. J Clin Pathol (2006) 1.17
Diabetes-induced extracellular matrix protein expression is mediated by transcription coactivator p300. Diabetes (2006) 1.16
Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe. J Hepatol (2011) 1.16
Percutaneous liver biopsy practice patterns among Canadian hepatologists. Can J Gastroenterol (2013) 1.15
High glucose-induced, endothelin-dependent fibronectin synthesis is mediated via NF-kappa B and AP-1. Am J Physiol Cell Physiol (2002) 1.14
Gene silencing of complement C5a receptor using siRNA for preventing ischemia/reperfusion injury. Am J Pathol (2008) 1.14
The role of Akt1 in terminal stages of endochondral bone formation: angiogenesis and ossification. Bone (2009) 1.12
EDB fibronectin and angiogenesis -- a novel mechanistic pathway. Angiogenesis (2005) 1.11
Growth factors in proliferative diabetic retinopathy. Exp Diabesity Res (2003) 1.11
Gastrointestinal stromal tumors: a contemporary review. Pathol Res Pract (2006) 1.11
Organ donation after cardiac death: donor and recipient outcomes after the first three years of the Ontario experience. Can J Anaesth (2011) 1.10
Infarct-like necrosis: a distinct form of necrosis seen in colorectal carcinoma liver metastases treated with perioperative chemotherapy. Am J Surg Pathol (2012) 1.10
Noninvasive prediction of cirrhosis in C282Y-linked hemochromatosis. Hepatology (2002) 1.10
Immune modulation and tolerance induction by RelB-silenced dendritic cells through RNA interference. J Immunol (2007) 1.10
Differential activation of NF-kappa B and AP-1 in increased fibronectin synthesis in target organs of diabetic complications. Am J Physiol Endocrinol Metab (2003) 1.09
Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis. J Hepatol (2011) 1.09
Inhibition of terminal complement components in presensitized transplant recipients prevents antibody-mediated rejection leading to long-term graft survival and accommodation. J Immunol (2007) 1.07
NK cells induce apoptosis in tubular epithelial cells and contribute to renal ischemia-reperfusion injury. J Immunol (2008) 1.07
Costimulation blockade in pig artery patch xenotransplantation - a simple model to monitor the adaptive immune response in nonhuman primates. Xenotransplantation (2012) 1.06
Preventing autoimmune arthritis using antigen-specific immature dendritic cells: a novel tolerogenic vaccine. Arthritis Res Ther (2006) 1.06
Endothelins in chronic diabetic complications. Can J Physiol Pharmacol (2003) 1.06
miR-195 regulates SIRT1-mediated changes in diabetic retinopathy. Diabetologia (2014) 1.06
Reinstalling antitumor immunity by inhibiting tumor-derived immunosuppressive molecule IDO through RNA interference. J Immunol (2006) 1.05
A novel in vivo siRNA delivery system specifically targeting dendritic cells and silencing CD40 genes for immunomodulation. Blood (2009) 1.04
Developments in the assessment of venous invasion in colorectal cancer: implications for future practice and patient outcome. Hum Pathol (2012) 1.04
Leptin-induced cardiomyocyte hypertrophy involves selective caveolae and RhoA/ROCK-dependent p38 MAPK translocation to nuclei. Cardiovasc Res (2007) 1.04
Increased risk of severe recurrence of hepatitis C virus in liver transplant recipients of donation after cardiac death allografts. Transplantation (2011) 1.03
The role of anti-non-Gal antibodies in the development of acute humoral xenograft rejection of hDAF transgenic porcine kidneys in baboons receiving anti-Gal antibody neutralization therapy. Transplantation (2006) 1.03
Grape seed and skin extracts inhibit platelet function and release of reactive oxygen intermediates. J Cardiovasc Pharmacol (2005) 1.02
Cellular signaling and potential new treatment targets in diabetic retinopathy. Exp Diabetes Res (2007) 1.02
Natural history of C282Y homozygotes for hemochromatosis. Can J Gastroenterol (2002) 1.02
Collagenous colitis and lymphocytic colitis: patient characteristics and clinical presentation. Scand J Gastroenterol (2005) 1.02
Liver diseases in the hemochromatosis and iron overload screening study. Clin Gastroenterol Hepatol (2006) 1.02
Defining readmission risk factors for liver transplantation recipients. Gastroenterol Hepatol (N Y) (2011) 1.01
Potential contributory role of H-Ras, a small G-protein, in the development of retinopathy in diabetic rats. Diabetes (2004) 1.01
miR-320 Regulates Glucose-Induced Gene Expression in Diabetes. ISRN Endocrinol (2012) 1.01
Heme oxygenase in diabetes-induced oxidative stress in the heart. J Mol Cell Cardiol (2003) 1.01
Co-localization of stanniocalcin-1 ligand and receptor in human breast carcinomas. Mol Cell Endocrinol (2004) 1.00
Vascular endothelial dysfunction in diabetic cardiomyopathy: pathogenesis and potential treatment targets. Pharmacol Ther (2005) 1.00
Outcomes of a 5-year follow-up of patients with sessile serrated adenomas. Scand J Gastroenterol (2012) 1.00
Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes. J Cell Mol Med (2014) 1.00
Upper gastrointestinal and intra-abdominal hemorrhage secondary to diffuse large B-cell gastric lymphoma. Can J Surg (2008) 0.98
Prevention of renal ischemic injury by silencing the expression of renal caspase 3 and caspase 8. Transplantation (2006) 0.98
Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level. Am J Physiol Endocrinol Metab (2008) 0.98
Perioperative neurological complications after liver transplantation are best predicted by pre-transplant hepatic encephalopathy. Neurocrit Care (2008) 0.98
Protection of renal ischemia injury using combination gene silencing of complement 3 and caspase 3 genes. Transplantation (2006) 0.97
A functional connection between pRB and transforming growth factor beta in growth inhibition and mammary gland development. Mol Cell Biol (2009) 0.97
Association of recanalization of the left umbilical vein with umbilical hernia in patients with liver disease. Liver Transpl (2005) 0.97
Differential effects of curcumin on vasoactive factors in the diabetic rat heart. Nutr Metab (Lond) (2006) 0.96
Treatment of autoimmune arthritis using RNA interference-modulated dendritic cells. J Immunol (2010) 0.96
Compensatory mechanisms influence hemostasis in setting of eNOS deficiency. Am J Physiol Heart Circ Physiol (2004) 0.96
Extracellular signal-regulated kinase (ERK) in glucose-induced and endothelin-mediated fibronectin synthesis. Lab Invest (2004) 0.96